ERYTECH to Host KOL Breakfast Symposium with Audio Webcast on November 7, 2018

  • Post author:
  • Post category:Newsroom

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a Key Opinion Leader (KOL) breakfast symposium, focused on the potential of eryaspase to treat patients with pancreatic cancer and triple-negative breast cancer, on Wednesday, November 7, 2018 from 8:00 A.M. – 11:00 A.M. ET in New York City.